| 19.21 -0.23 (-1.18%) | 10-08 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 25.26  |
1-year : | 27.16 |
| Resists | First : | 21.62 |
Second : | 23.25 |
| Pivot price | 20.76 |
|||
| Supports | First : | 19 |
Second : | 15.8 |
| MAs | MA(5) : | 19.75 |
MA(20) : | 21.02 |
| MA(100) : | 19.74  |
MA(250) : | 19.19 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 6.7 |
D(3) : | 10 |
| RSI | RSI(14): 32.2 |
|||
| 52-week | High : | 27.88 | Low : | 12.84 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ STVN ] has closed above bottom band by 4.2%. Bollinger Bands are 35.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 19.58 - 19.72 | 19.72 - 19.82 |
| Low: | 18.64 - 18.83 | 18.83 - 18.97 |
| Close: | 18.95 - 19.2 | 19.2 - 19.4 |
Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.
Thu, 08 Oct 2026
Fenimore Asset Management Inc Buys 582,070 Shares of Stevanato Group S.p.A. $STVN - MarketBeat
Wed, 07 Oct 2026
Deutsche Bank Aktiengesellschaft Initiates Coverage on Stevanato Group (NYSE:STVN) - MarketBeat
Thu, 01 Oct 2026
Is Stevanato Group SpA (STVN) a Bargain After 4.8% Drop? GF Value Says Undervalued - GuruFocus
Thu, 01 Oct 2026
Stevanato Group S.p.A. (NYSE:STVN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Mon, 10 Aug 2026
Stevanato Group (STVN) Stock Looks Cheap On Cash Flow But Pricey On Earnings - Yahoo Finance
Tue, 04 Aug 2026
Stevanato Group SpA (STVN) (Q2 2026) Earnings Call Highlights: Biologics Surge and Alina ... - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 50 (M) |
| Shares Float | 49 (M) |
| Held by Insiders | 1.6 (%) |
| Held by Institutions | 97.8 (%) |
| Shares Short | 1,190 (K) |
| Shares Short P.Month | 1,030 (K) |
| EPS | 0.56 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.5 |
| Profit Margin | 10.9 % |
| Operating Margin | 17.2 % |
| Return on Assets (ttm) | 5.4 % |
| Return on Equity (ttm) | 9.1 % |
| Qtrly Rev. Growth | 7.8 % |
| Gross Profit (p.s.) | 7.22 |
| Sales Per Share | 24.68 |
| EBITDA (p.s.) | 5.99 |
| Qtrly Earnings Growth | -26.5 % |
| Operating Cash Flow | 249 (M) |
| Levered Free Cash Flow | -105 (M) |
| PE Ratio | 34.3 |
| PEG Ratio | 1.5 |
| Price to Book value | 2.95 |
| Price to Sales | 0.77 |
| Price to Cash Flow | 3.84 |
| Dividend | 0.05 |
| Forward Dividend | 0 |
| Dividend Yield | 0.3% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|